GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BSF Enterprise PLC (OTCPK:BSFAF) » Definitions » Valuation Rank

BSFAF (BSF Enterprise) Valuation Rank


View and export this data going back to 2023. Start your Free Trial

What is BSF Enterprise Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

BSF Enterprise Valuation Rank Related Terms

Thank you for viewing the detailed overview of BSF Enterprise's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

BSF Enterprise Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BSF Enterprise PLC (OTCPK:BSFAF) » Definitions » Valuation Rank
Comparable Companies
LSE:VAL LSE:NFX LSE:PYC LSE:ONC LSE:ROQ LSE:CRTX LSE:GENF LSE:TCF LSE:APTA AQSE:INC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
BSFA:UK
Address
2 Portman Street, London, GBR, W1H 6DU
Website
https://www.bsfenterprise.com
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people.